ArticleCancer medicine2025

Baseline FIB-4 May Be a Risk Factor of Recurrence After SBRT in Patients With HBV-Related Small HCC.

Zhan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.